The estimated Net Worth of Donnell Michael J O is at least $362 Tausend dollars as of 7 March 2023. Mr. O owns over 7,142 units of Cassava Sciences Inc stock worth over $328,288 and over the last 10 years he sold SAVA stock worth over $0. In addition, he makes $33,372 as Independent Director at Cassava Sciences Inc.
Sign up
Mr. Donnell SAVA stock SEC Form 4 insiders trading
Michael has made over 2 trades of the Cassava Sciences Inc stock since 2021, according to the Form 4 filled with the SEC. Most recently he exercised 7,142 units of SAVA stock worth $129,484 on 7 March 2023.
The largest trade he's ever made was exercising 7,142 units of Cassava Sciences Inc stock on 7 March 2023 worth over $129,484. On average, Michael trades about 1,074 units every 66 days since 2014. As of 7 March 2023 he still owns at least 12,012 units of Cassava Sciences Inc stock.
You can see the complete history of Mr. O stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Michael O' Donnell biography
Michael J. O' Donnell Esq., J.D. serves as Independent Director of the Company. Mr. O’Donnell has been a member of the law firm of Morrison & Foerster, LLP since 2011. Morrison & Foerster, LLP is the Company’s corporate counsel and provides legal services to the Company. Mr. O’Donnell serves as corporate counsel to numerous public and private biopharmaceutical and life sciences companies. Previously, Mr. O’Donnell was a member of Wilson Sonsini Goodrich & Rosati. Mr. O’Donnell received his J.D., cum laude, from Harvard University and his B.A. from Bucknell University, summa cum laude.
What is the salary of Michael Donnell?
As the Independent Director of Cassava Sciences Inc, the total compensation of Michael Donnell at Cassava Sciences Inc is $33,372. There are 8 executives at Cassava Sciences Inc getting paid more, with Remi Barbier having the highest compensation of $1,073,230.
How old is Michael Donnell?
Michael Donnell is 61, he's been the Independent Director of Cassava Sciences Inc since . There are 5 older and 3 younger executives at Cassava Sciences Inc. The oldest executive at Cassava Sciences Inc is Sanford Robertson, 88, who is the Independent Director.
What's Michael Donnell's mailing address?
Donnell's mailing address filed with the SEC is 6801 N CAPITAL OF TEXAS HWY, BLDG 1, SUITE 300, AUSTIN, TX, 78731.
Insiders trading at Cassava Sciences Inc
Over the last 5 years, insiders at Cassava Sciences Inc have traded over $0 worth of Cassava Sciences Inc stock and bought 1,178,376 units worth $9,853,781 . The most active insiders traders include Sanford Robertson, Richard Barry und Patrick J Md Phd Scannon. On average, Cassava Sciences Inc executives and independent directors trade stock every 45 days with the average trade being worth of $1,235,207. The most recent stock trade was executed by Sanford Robertson on 26 April 2024, trading 69,000 units of SAVA stock currently worth $1,518,000.
What does Cassava Sciences Inc do?
refer to descriptions included in the company's filings with the securities and exchange commission for more information about the company. the company does not intend to update and does not take responsibility for any information published on linkedin.
What does Cassava Sciences Inc's logo look like?
Complete history of Mr. O stock trades at Cassava Sciences Inc
Cassava Sciences Inc executives and stock owners
Cassava Sciences Inc executives and other stock owners filed with the SEC include:
-
Remi Barbier,
Chairman of the Board, President, Chief Executive Officer -
Remi Barbier,
Founder, Chairman, Pres & CEO -
Nadav Friedmann,
Chief Medical and Operating Officer, Director -
Dr. Nadav Friedmann,
Chief Medical Officer & Director -
Eric J. Schoen,
Chief Financial Officer -
Eric Schoen,
Chief Financial Officer -
Sanford Robertson,
Independent Director -
Robert Gussin,
Independent Director -
Patrick Scannon,
Independent Director -
Michael O' Donnell,
Independent Director -
Dr. James W. Kupiec M.D.,
Chief Clinical Devel. Officer -
Dr. Lindsay H. Burns Ph.D.,
Sr. VP of Neuroscience -
Dr. Michael Marsman,
Sr. VP of Regulatory Affairs -
Michael Zamloot,
Sr. VP of Technical Operations -
Dr. George Thornton,
Sr. VP of Technology -
Saira Ramasastry,
Director -
Pierre Gravier,
Director -
Claude Nicaise,
Director -
Robert Christopher Cook,
SVP & General Counsel -
Richard Barry,
Director -
James William Kupiec,
Chief Medical Officer -
Robert Eugene Jr Anderson,
Director